Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitepromethera.com
CategoryBioTech
Phone+32 (0)10 39 43 00
Emailcontact@promether...
Employees

Offices

Mont-Saint-Guibert, BEL
Watson & Crick Hill
Rue Granbonpré, 11
Mont-Saint-Guibert, B-1435, BEL

People

Funding

Tags

Promethera Biosciences

Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology.

Promethera® Biosciences’ mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers.

Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Recent Milestones

Videos

Screenshots

Promethera Biosciences screenshot
Above: Home Page
Uploaded: 2/3/10

Sources

  1. Promethera Biosciences, SA: Series A $7.3M (onbiovc.com) [edit]
  2. Promethera Biosciences Raises €23.6M in Series B Funding (finsmes.com) [edit]
Edit This Page
Last Edited 3/28/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy